Brief: Reneo Pharmaceuticals Reports Q4 Loss Per Share Of $0.56

Onkure Therapeutics

27/03/2023 12:35

March 27 (Reuters) - Reneo Pharmaceuticals Inc  RPHM.O :
    * RENEO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.56
    * NET LOSS OF $13.6 MILLION, OR $0.56 PER SHARE, DURING Q4
OF 2022
    * Q4 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3HMtv1 
Further company coverage:  RPHM.O 

 ((Reuters.Briefs@thomsonreuters.com;))